LB Pharmaceuticals Inc Common Stock (LBRX)
Healthcare
Biotechnology
42.80 $
+6.9%
vs. previous close
Closing price · As of: 3. Aug 2026
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of LB Pharmaceuticals Inc Common Stock (LBRX) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 07/29/2026 | Current report (8-K) | LB PHARMACEUTICALS INC (LBRX): Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Disclosure; Financial Statements and Exhibits | View report → |
| 07/22/2026 | Current report (8-K) | LB PHARMACEUTICALS INC (LBRX): Other Events; Financial Statements and Exhibits | View report → |
Showing the 100 most recent filings of the selected type.
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.